Market Closed

BCTX
BriaCell Therapeutics Corp.
$ 3.39
-3.42%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago

BriaCell Therapeutics Corp. News

Latest BriaCell Therapeutics Corp. Stock News & BCTX Headlines

Briacell Therap (NASDAQ:BCTX) Shares Break Above 200 Day Moving Average – Should You Sell?
8 days ago | defenseworld.net
BriaCell Therapeutics Announces Closing of Offering
5 months ago | globenewswire.com
BriaCell Presents Positive Clinical Data at ASCO 2026
5 months ago | globenewswire.com
BriaCell Therapeutics Announces Pricing of Offering
5 months ago | globenewswire.com
BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer
6 months ago | globenewswire.com
BriaCell Presentations Highlight Positive Clinical Data for Bria-IMT™ at ASCO 2026
6 months ago | globenewswire.com
BriaCell Expands Pipeline to Include an Ovarian Cancer Immunotherapy Candidate, Bria-OVA+™
6 months ago | globenewswire.com
BriaCell Completes Manufacturing of Clinical Supplies of Bria-PROS+™ for Prostate Cancer
6 months ago | globenewswire.com
BriaCell Adds Penn Medicine's Abramson Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study
6 months ago | globenewswire.com
BriaCell Phase 3 Bria-IMT™ Study Enrollment Surpasses 230 Patients
6 months ago | globenewswire.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

BCTX
BriaCell Therapeutics Corp.
$ 3.39
-3.42%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago